Previous experiments suggest a dynamic model for class II intracellular trafficking, which is regulated by conformational alternatives in the peptide binding domain. The focus of the experiments in this proposal are to test this model and explore the role of hydrogen bonds between class II and its bound peptide. The investigator will: 1. Delineate the contribution of hydrogen bonds to class II peptide binding. Loss of a single hydrogen bond between class II and peptide has been shown to have dramatic consequences on peptide binding and intracellular trafficking. The consequences of hydrogen bond loss at other sites will be explored, using PCR mutagenesis coupled with peptide binding and cell biology studies. 2. Determine the specificity of CLIP to the function of Ii in class II biochemistry and function. The Ii-derived CLIP segment is critical for assembly of Ii with the class II molecule. In the experiments in this Aim, they will determine whether the amino acid sequence of CLIP contributes unique aspects to the fate of class II, and whether the affinity of the """"""""CLIP"""""""" peptide for class II affects the biological consequences of Ii. 3. Determine whether peptide occupancy changes the intracellular fate of 81m and 82m. In this Aim, the investigator will evaluate whether peptides that have stable peptide binding to mutant class II molecules can change their fate within cells. Ii constructs with high affinity peptides in the """"""""CLIP"""""""" segment of Ii will be introduced into the mutant cells and consequences on their intracellular fate will be evaluated. 4. Evaluate the role of hydrogen bonds to the interaction of class II molecules with DM and on intracellular trafficking of class II molecules. A model for DM function is that it stabilizes an alternate conformational state of the class II molecule that favors peptide dissociation. The investigator will test whether this involves de-stabilization of hydrogen bonds between class II and peptide. Mutant molecules with altered potential for hydrogen bonds will be tested for altered interactions with DM and post-endosomal sorting. These experiments will provide insight into the basic molecular mechanism of DM function and may reveal influences of DM on the intracellular targeting of normal class II molecules that relate to peptide occupancy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
7R01AI034359-10
Application #
6660664
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Gondre-Lewis, Timothy A
Project Start
1994-05-01
Project End
2004-03-31
Budget Start
2002-08-01
Budget End
2004-03-31
Support Year
10
Fiscal Year
2002
Total Cost
$250,038
Indirect Cost
Name
University of Rochester
Department
Microbiology/Immun/Virology
Type
Schools of Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Lazarski, Christopher A; Chaves, Francisco A; Jenks, Scott A et al. (2005) The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance. Immunity 23:29-40
McFarland, Benjamin J; Katz, John F; Sant, Andrea J et al. (2005) Energetics and cooperativity of the hydrogen bonding and anchor interactions that bind peptides to MHC class II protein. J Mol Biol 350:170-83
Chaves, Francisco A; Hou, Ping; Wu, Shenhong et al. (2005) Replacement of the membrane proximal region of I-A(d) MHC class II molecule with I-E-derived sequences promotes production of an active and stable soluble heterodimer without altering peptide-binding specificity. J Immunol Methods 300:74-92
McFarland, B J; Katz, J F; Beeson, C et al. (2001) Energetic asymmetry among hydrogen bonds in MHC class II*peptide complexes. Proc Natl Acad Sci U S A 98:9231-6
Arneson, L S; Katz, J F; Liu, M et al. (2001) Hydrogen bond integrity between MHC class II molecules and bound peptide determines the intracellular fate of MHC class II molecules. J Immunol 167:6939-46
Arneson, L S; Peterson, M; Sant, A J (2000) The MHC class II molecule I-Ag7 exists in alternate conformations that are peptide dependent. J Immunol 165:2059-67
McFarland, B J; Sant, A J; Lybrand, T P et al. (1999) Ovalbumin(323-339) peptide binds to the major histocompatibility complex class II I-A(d) protein using two functionally distinct registers. Biochemistry 38:16663-70
McFarland, B J; Beeson, C; Sant, A J (1999) Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes. J Immunol 163:3567-71
Ceman, S; Wu, S; Jardetzky, T S et al. (1998) Alteration of a single hydrogen bond between class II molecules and peptide results in rapid degradation of class II molecules after invariant chain removal. J Exp Med 188:2139-49
Peterson, M; Sant, A J (1998) The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM. J Immunol 161:2961-7

Showing the most recent 10 out of 13 publications